Covidien Ventures is a venture capital group focused on investing in companies developing innovative new medical devices, diagnostics and pharmaceuticals. We look to partner with management teams and other investors to help bring new technologies to the physicians and patients in need of them. With our extensive experience as both operators and investors, we understand the steep climb that pioneering companies must make to commercialize new ideas. We view our investment in a portfolio company as only the first step in a long-term partnership designed to create significant shareholder value.
Covidien Ventures is the venture capital investment arm of Covidien plc, the healthcare company spun off by Tyco International. Our investment interests are in markets, products, and technologies that are of long-term interest to Covidien.
Covidien Ventures brings the resources of a large healthcare-focused company which enables start-up companies to gain access to valuable skills and expertise. When appropriate, our affiliation with Covidien uniquely positions us to provide these companies direct access to Covidien senior management. We understand, however, the need to protect our portfolio companies’ confidential information.